SO
ENTA icon

STRS Ohio’s Enanta Pharmaceuticals ENTA Stock Holding History

STRS Ohio’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.4K Hold
3,200
– – ﹤0.01% 1969
2025
Q4 		$50.5K Buy
+3,200
New +$40.6K ﹤0.01% 1978
2024
Q4 		– Sell
-12,100
Closed -$125K – 1931
2024
Q3 		$125K Hold
12,100
– – ﹤0.01% 1664
2024
Q2 		$157K Sell
12,100
-3,900
-24% -$52.6K ﹤0.01% 1614
2024
Q1 		$279K Sell
16,000
-2,700
-14% -$35.7K ﹤0.01% 1465
2023
Q4 		$175K Buy
18,700
+3,200
+21% +$29.8K ﹤0.01% 1601
2023
Q3 		$173K Hold
15,500
– – ﹤0.01% 1599
2023
Q2 		$331K Buy
15,500
+1,200
+8% +$35.4K ﹤0.01% 1445
2023
Q1 		$578K Hold
14,300
– – ﹤0.01% 1217
2022
Q4 		$665K Hold
14,300
– – ﹤0.01% 1136
2022
Q3 		$741K Sell
14,300
-600
-4% -$35.1K ﹤0.01% 1083
2022
Q2 		$704K Buy
14,900
+800
+6% +$43.4K ﹤0.01% 1134
2022
Q1 		$1M Hold
14,100
– – ﹤0.01% 1034
2021
Q4 		$1.05M Buy
14,100
+3,700
+36% +$290K ﹤0.01% 1089
2021
Q3 		$590K Sell
10,400
-4,600
-31% -$227K ﹤0.01% 1442
2021
Q2 		$660K Buy
15,000
+1,400
+10% +$68.6K ﹤0.01% 1467
2021
Q1 		$670K Hold
13,600
– – ﹤0.01% 1442
2020
Q4 		$572K Hold
13,600
– – ﹤0.01% 1405
2020
Q3 		$622K Hold
13,600
– – ﹤0.01% 1206
2020
Q2 		$682K Buy
13,600
+1,100
+9% +$56.9K ﹤0.01% 1094
2020
Q1 		$642K Hold
12,500
– – ﹤0.01% 954
2019
Q4 		$772K Buy
12,500
+700
+6% +$43.4K ﹤0.01% 1096
2019
Q3 		$708K Buy
11,800
+800
+7% +$59.4K ﹤0.01% 978
2019
Q2 		$928K Buy
11,000
+10,100
+1,122% +$909K ﹤0.01% 861
2019
Q1 		$85K Hold
900
– – ﹤0.01% 1814
2018
Q4 		$63K Sell
900
-10,700
-92% -$820K ﹤0.01% 1839
2018
Q3 		$991K Buy
11,600
+800
+7% +$80.1K ﹤0.01% 884
2018
Q2 		$1.25M Sell
10,800
-900
-8% -$89.8K 0.01% 793
2018
Q1 		$946K Sell
11,700
-5,100
-30% -$393K ﹤0.01% 888
2017
Q4 		$985K Sell
16,800
-700
-4% -$35.1K ﹤0.01% 859
2017
Q3 		$819K Sell
17,500
-2,900
-14% -$117K ﹤0.01% 999
2017
Q2 		$733K Sell
20,400
-2,000
-9% -$64K ﹤0.01% 1046
2017
Q1 		$689K Sell
22,400
-600
-3% -$18.7K ﹤0.01% 1111
2016
Q4 		$770K Sell
23,000
-2,700
-11% -$77.4K ﹤0.01% 1011
2016
Q3 		$683K Sell
25,700
-3,300
-11% -$76.6K ﹤0.01% 1075
2016
Q2 		$639K Buy
29,000
+4,800
+20% +$126K ﹤0.01% 1132
2016
Q1 		$710K Buy
24,200
+1,700
+8% +$47.3K ﹤0.01% 993
2015
Q4 		$742K Buy
22,500
+2,000
+10% +$65.2K ﹤0.01% 988
2015
Q3 		$740K Buy
20,500
+2,000
+11% +$85.9K ﹤0.01% 996
2015
Q2 		$832K Sell
18,500
-4,400
-19% -$171K ﹤0.01% 984
2015
Q1 		$701K Buy
22,900
+5,000
+28% +$195K ﹤0.01% 1040
2014
Q4 		$910K Hold
17,900
– – ﹤0.01% 848
2014
Q3 		$708K Buy
17,900
+900
+5% +$35.9K ﹤0.01% 947
2014
Q2 		$732K Buy
17,000
+400
+2% +$15.3K ﹤0.01% 1001
2014
Q1 		$664K Buy
16,600
+7,900
+91% +$287K ﹤0.01% 1015
2013
Q4 		$237K Sell
8,700
-1,000
-10% -$24.2K ﹤0.01% 1407
2013
Q3 		$222K Buy
9,700
+8,000
+471% +$153K ﹤0.01% 1461
2013
Q2 		$30K Buy
+1,700
New +$33.1K ﹤0.01% 1777

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

STRS Ohio's ENTA Position: Q1 2026 in Review

STRS Ohio held its Enanta Pharmaceuticals (ENTA) position steady in Q1 2026 at 3,200 shares worth $40.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1969.

STRS Ohio first reported a position in ENTA in Q2 2013 and has held it in 48 quarters since. The position peaked at $1.25M in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • STRS Ohio held 3,200 shares of Enanta Pharmaceuticals worth $40.4K as of Q1 2026.
  • STRS Ohio left its Enanta Pharmaceuticals share count unchanged in Q1 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1969 holding.
  • STRS Ohio first reported a position in Enanta Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
  • STRS Ohio's Enanta Pharmaceuticals position peaked at $1.25M in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.